DALZIEL BRUCE D 4
4 · ORCHID CELLMARK INC · Filed Dec 19, 2011
Insider Transaction Report
Form 4
DALZIEL BRUCE D
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−61,882$173,270→ 0 totalExercise: $1.88Exp: 2020-04-01→ Common Stock (61,882 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−18,439$51,629→ 0 totalExercise: $2.03Exp: 2020-05-05→ Common Stock (18,439 underlying)
Footnotes (2)
- [F1]This option was cancelled in exchange for a cash payment of $56,931, representing the difference between the exercise price of the option and the offer price ($2.80 per share) pursuant to the Agreement and Plan of Merger between Laboratory Corporation of America Holdings, OCM Acquisition Corp. and Orchid Cellmark Inc., dated as of April 5, 2011, as amended (the "Merger Agreement").
- [F2]This option was cancelled in exchange for a cash payment of $14,198, representing the difference between the exercise price of the option and the offer price ($2.80 per share) pursuant to the Merger Agreement.